Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals, 70422-70423 [2023-22465]
Download as PDF
<![CDATA[
70422
Federal Register / Vol. 88, No. 195 / Wednesday, October 11, 2023 / Notices
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)).
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than November 13, 2023.
A. Federal Reserve Bank of Dallas
(Karen Smith, Director, Mergers &
Acquisitions) 2200 North Pearl Street,
Dallas, Texas 75201–2272. Comments
can also be sent electronically to
Comments.applications@dal.frb.org:
1. Unifi Financial, Inc., San Antonio,
Texas; to become a bank holding
company by acquiring Stockmens
National Bank in Cotulla, Cotulla,
Texas.
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2023–22490 Filed 10–10–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA–2013–N–0804; FDA–
2010–N–0598; FDA–2022–N–0081; FDA–
2022–N–1886; FDA–2022–N–2657; FDA–
2023–N–0895; FDA–2023–N–0343; FDA–
2023–N–0134; FDA–2022–N–3208; FDA–
2017–N–0084; FDA–2023–N–1168; FDA–
2016–N–2474; FDA–2014–N–0086; FDA–
2017–N–0366; FDA–2019–N–3657; FDA–
2023–N–0155; FDA–2010–N–0601; FDA–
2023–N–2757]
ACTION:
Notice.
The Food and Drug
Administration (FDA) is publishing a
list of information collections that have
been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
JonnaLynn Capezzuto, Office of
Operations, Food and Drug
Administration, Three White Flint
North, 10A–12M, 11601 Landsdown St.,
North Bethesda, MD 20852, 301–796–
3794, PRAStaff@fda.hhs.gov.
The
following is a list of FDA information
collections recently approved by OMB
under section 3507 of the Paperwork
Reduction Act of 1995 (44 U.S.C. 3507).
The OMB control number and
expiration date of OMB approval for
each information collection are shown
in table 1. Copies of the supporting
statements for the information
collections are available on the internet
at https://www.reginfo.gov/public/do/
PRAMain. An Agency may not conduct
or sponsor, and a person is not required
to respond to, a collection of
information unless it displays a
currently valid OMB control number.
SUPPLEMENTARY INFORMATION:
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approvals
AGENCY:
Food and Drug Administration,
HHS.
TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB
OMB control
No.
lotter on DSK11XQN23PROD with NOTICES1
Title of collection
Premarket Notification Submission 510(k), Subpart E ............................................................................................
Good Manufacturing Practice Regulations for Type A Medicated Articles .............................................................
Tradeoff Analysis of Prescription Drug Product Claims in Direct-to-Consumer and Healthcare Provider Promotion ...................................................................................................................................................................
Endorser Status and Actual Use in Direct-to-Consumer Television Ads ................................................................
Assessing Physiological, Neural and Self-Reported Response to Tobacco Education Messages ........................
Imports and Electronic Import Entries .....................................................................................................................
Current Good Manufacturing Practices for Blood and Related Regulations for and Blood Components; and Requirements for Donor Testing, Donor Notification, and ‘‘Lookback’’ ...................................................................
Administrative Practices and Procedures; Formal Hearings ...................................................................................
Adverse Experience/Events with Approved New Animal Drugs .............................................................................
Adverse Event Program for Medical Devices (Medical Product Safety Network (MedSun)) .................................
Human Cells, Tissues, and Cellular and Tissue-Based Products ..........................................................................
New Animal Drugs for Minor Use and Minor Species ............................................................................................
Potential Tobacco Product Violations Reporting Form ...........................................................................................
Food and Drug Administration Advisory Committee Regulations ...........................................................................
Accreditation Scheme for Conformity Assessment Program ..................................................................................
Quantitative Research on Front of Package Labeling on Packaged Foods ...........................................................
Current Good Manufacturing Practice Regulations for Medicated Feed ................................................................
Medical Devices—Voluntary Improvement Program ...............................................................................................
VerDate Sep<11>2014
17:49 Oct 10, 2023
Jkt 262001
PO 00000
Frm 00009
Fmt 4703
Sfmt 4703
E:\FR\FM\11OCN1.SGM
11OCN1
Date approval
expires
0910–0120
0910–0154
7/31/2026
7/31/2026
0910–0917
0910–0918
0910–0919
0910–0046
7/31/2026
7/31/2026
7/31/2026
8/31/2026
0910–0116
0910–0191
0910–0284
0910–0471
0910–0543
0910–0605
0910–0716
0910–0833
0910–0889
0910–0920
0910–0152
0910–0922
8/31/2026
8/31/2026
8/31/2026
8/31/2026
8/31/2026
8/31/2026
8/31/2026
8/31/2026
8/31/2026
8/31/2026
9/30/2026
9/30/2026
Federal Register / Vol. 88, No. 195 / Wednesday, October 11, 2023 / Notices
Dated: October 5, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–22465 Filed 10–10–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute on
Drug Abuse Special Emphasis Panel,
November 8, 2023, 10:00 a.m. to
November 8, 2023, 5:00 p.m., National
Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD
20892 which was published in the
Federal Register on October 3, 2023, FR
Doc. 2023–21775, 88–FR 68128. This
notice is being amended to change the
meeting contact person from Dr. Preethy
Nayar to Dr. Jenny Raye Browning,
Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Research, National Institute on Drug
Abuse, NIH, (301) 443–4577,
jenny.browning@nih.gov. The meeting
date, time and location will remain the
same. The meeting is closed to the
public.
Dated: October 4, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–22444 Filed 10–10–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
National Park Service
National Park Service, Interior.
Notice.
AGENCY:
The National Park Service is
soliciting electronic comments on the
significance of properties nominated
before September 30, 2023, for listing or
related actions in the National Register
of Historic Places.
DATES: Comments should be submitted
electronically by October 26, 2023.
ADDRESSES: Comments are encouraged
to be submitted electronically to
National_Register_Submissions@
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:49 Oct 10, 2023
Jkt 262001
DISTRICT OF COLUMBIA
FOR FURTHER INFORMATION CONTACT:
Buildings at 523–549 Stewart Avenue, 565
Northside Dr. SW, 523 to 529 Metropolitan
Parkway, 523 Stewart Avenue, 35 Stewart
Avenue, Atlanta, SG100009517
Capitol View Apartments, 1191 Metropolitan
Parkway, Atlanta, SG100009520
Sherry A. Frear, Chief, National Register
of Historic Places/National Historic
Landmarks Program, 1849 C Street NW,
MS 7228, Washington, DC 20240,
sherry_frear@nps.gov, 202–913–3763.
The
properties listed in this notice are being
considered for listing or related actions
in the National Register of Historic
Places. Nominations for their
consideration were received by the
National Park Service before September
30, 2023. Pursuant to Section 60.13 of
36 CFR part 60, comments are being
accepted concerning the significance of
the nominated properties under the
National Register criteria for evaluation.
Before including your address, phone
number, email address, or other
personal identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Nominations submitted by State or
Tribal Historic Preservation Officers.
Key: State, County, Property Name,
Multiple Name (if applicable), Address/
Boundary, City, Vicinity, Reference
Number.
SUPPLEMENTARY INFORMATION:
District of Columbia
Eastern High School, (Public School
Buildings of Washington, DC MPS), 1730
East Capitol Street NE, Washington,
MP100009489
GEORGIA
Fulton County
IOWA
Dallas County
Redfield GAR Hall, 1213 Thomas St.,
Redfield, SG100009484
Henry County
West Main Street Residential Historic
District, 301–407 and 302–402 W Main St.,
Wayland, SG100009485
Louisa County
Fairview Church and Cemetery, 11501 Co Rd.
H22, Wapello vicinity, SG100009486
Muscatine County
Nichols, Benjamin F. and Susan M. (Jenkins),
House, 815 Ijem Avenue, Nichols,
SG100009487
Fairport Biological Station Historic District,
3390 Highway 22, Fairport vicinity,
SG100009488
KENTUCKY
Bath County
Sharpsburg Historic District, Main Street,
Back Street, Public Street, Camp Street,
West Tunnel Hill Road, Forest Avenue,
Sharpsburg, SG100009521
Boone County
Dinsmore House, (Boone County, Kentucky
MPS), W of Burlington on KY 18,
Burlington vicinity, MP79000962
Boyle County
Los Angeles County
Watts Happening Cultural Center, 1827 E
103rd St., Los Angeles, SG100009466
National Register of Historic Places;
Notification of Pending Nominations
and Related Actions
ACTION:
nps.gov with the subject line ‘‘Public
Comment on <property or proposed
district name, (County) State>.’’ If you
have no access to email, you may send
them via U.S. Postal Service and all
other carriers to the National Register of
Historic Places, National Park Service,
1849 C Street NW, MS 7228,
Washington, DC 20240.
CALIFORNIA
[NPS–WASO–NRNHL–DTS#–36725;
PPWOCRADI0, PCU00RP14.R50000]
70423
The Norton Center for the Arts, 600 West
Walnut Street, Danville, SG100009524
Bracken County
Riverside County
Evergreen Cemetery, 4414 Fourteenth St.,
Riverside, SG100009467
F.A. Neider Company, (Augusta MRA), 207
Seminary, Augusta, MP100009535
San Bernardino County
City Transfer and Storage Company
Warehouse, 440 Oriental Ave., Redlands,
SG100009474
Terrace Gardens, 1300 Dayton Avenue,
Dayton, SG100009534
Tuolumne County
Sierra Railway Locomotive No. 3, 10501
Reservoir Rd., Jamestown, SG100009468
DELAWARE
Sussex County
Prospect A.M.E. Church, 220 South Railroad
Ave., Georgetown, SG100009498
PO 00000
Frm 00010
Fmt 4703
Sfmt 4703
Campbell County
Jefferson County
Olds Motor Works, 728–730 S 4th Street,
Louisville, SG100009532
East Smoketown District, 733, 801–827, 829
Logan Street, 929, 930 Mason Avenue, 925,
935 Lampton Street, South Fork of
Beargrass Creek, Louisville, SG100009533
Kenton County
Magnus Metal Company Building, 4 Highway
Avenue, Ludlow, SG100009531
E:\FR\FM\11OCN1.SGM
11OCN1
]]>Agencies
[Federal Register Volume 88, Number 195 (Wednesday, October 11, 2023)]
[Notices]
[Pages 70422-70423]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22465]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2013-N-0804; FDA-2010-N-0598; FDA-2022-N-0081; FDA-
2022-N-1886; FDA-2022-N-2657; FDA-2023-N-0895; FDA-2023-N-0343; FDA-
2023-N-0134; FDA-2022-N-3208; FDA-2017-N-0084; FDA-2023-N-1168; FDA-
2016-N-2474; FDA-2014-N-0086; FDA-2017-N-0366; FDA-2019-N-3657; FDA-
2023-N-0155; FDA-2010-N-0601; FDA-2023-N-2757]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approvals
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is publishing a list of
information collections that have been approved by the Office of
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of
Operations, Food and Drug Administration, Three White Flint North, 10A-
12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-3794,
[email protected].
SUPPLEMENTARY INFORMATION: The following is a list of FDA information
collections recently approved by OMB under section 3507 of the
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control
number and expiration date of OMB approval for each information
collection are shown in table 1. Copies of the supporting statements
for the information collections are available on the internet at
https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number.
Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
OMB control Date approval
Title of collection No. expires
------------------------------------------------------------------------
Premarket Notification Submission 0910-0120 7/31/2026
510(k), Subpart E......................
Good Manufacturing Practice Regulations 0910-0154 7/31/2026
for Type A Medicated Articles..........
Tradeoff Analysis of Prescription Drug 0910-0917 7/31/2026
Product Claims in Direct-to-Consumer
and Healthcare Provider Promotion......
Endorser Status and Actual Use in Direct- 0910-0918 7/31/2026
to-Consumer Television Ads.............
Assessing Physiological, Neural and Self- 0910-0919 7/31/2026
Reported Response to Tobacco Education
Messages...............................
Imports and Electronic Import Entries... 0910-0046 8/31/2026
Current Good Manufacturing Practices for 0910-0116 8/31/2026
Blood and Related Regulations for and
Blood Components; and Requirements for
Donor Testing, Donor Notification, and
``Lookback''...........................
Administrative Practices and Procedures; 0910-0191 8/31/2026
Formal Hearings........................
Adverse Experience/Events with Approved 0910-0284 8/31/2026
New Animal Drugs.......................
Adverse Event Program for Medical 0910-0471 8/31/2026
Devices (Medical Product Safety Network
(MedSun))..............................
Human Cells, Tissues, and Cellular and 0910-0543 8/31/2026
Tissue-Based Products..................
New Animal Drugs for Minor Use and Minor 0910-0605 8/31/2026
Species................................
Potential Tobacco Product Violations 0910-0716 8/31/2026
Reporting Form.........................
Food and Drug Administration Advisory 0910-0833 8/31/2026
Committee Regulations..................
Accreditation Scheme for Conformity 0910-0889 8/31/2026
Assessment Program.....................
Quantitative Research on Front of 0910-0920 8/31/2026
Package Labeling on Packaged Foods.....
Current Good Manufacturing Practice 0910-0152 9/30/2026
Regulations for Medicated Feed.........
Medical Devices--Voluntary Improvement 0910-0922 9/30/2026
Program................................
------------------------------------------------------------------------
[[Page 70423]]
Dated: October 5, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-22465 Filed 10-10-23; 8:45 am]
BILLING CODE 4164-01-P
